{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:36:31Z","timestamp":1791423391268,"version":"4.3.3"},"reference-count":82,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.tips.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T16:45:21Z","timestamp":1415205921000},"page":"664-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Resistance-resistant antibiotics"],"prefix":"10.1016","volume":"35","author":[{"given":"Eric","family":"Oldfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2014.10.007_bib0005","series-title":"Threat Report 2013: Antibiotic\/Antimicrobial Resistance","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.tips.2014.10.007_bib0010","series-title":"Antimicrobial Resistance: Global Report on Surveillance 2014","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.tips.2014.10.007_bib0015","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2014.10.007_bib0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2471\/BLT.09.051009","article-title":"Ancient Chinese anti-fever cure becomes panacea for malaria","volume":"87","author":"Cui","year":"2009","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.tips.2014.10.007_bib0025","series-title":"A Detailed Chronological Record of Project 523 and the Discovery and Development if Qinghaosu (Artemisinin)","author":"Zhang","year":"2013"},{"key":"10.1016\/j.tips.2014.10.007_bib0030","series-title":"The Fever Trail: In Search of the Cure for Malaria","author":"Honigsbaum","year":"2002"},{"key":"10.1016\/j.tips.2014.10.007_bib0035","first-page":"337","article-title":"Suite des researches chimiques sur les quinquinas","volume":"15","author":"Pelletier","year":"1820","journal-title":"Ann. Chim. Phys."},{"key":"10.1016\/j.tips.2014.10.007_bib0040","series-title":"Ways of Regulating Drugs in the 19th and 20th Centuries","first-page":"43","article-title":"Making Salvarsan: experimental therapy and the development and marketing of Salvarsan at the interface between science, clinic, industry and public health","author":"H\u00fcntelmann","year":"2012"},{"key":"10.1016\/j.tips.2014.10.007_bib0045","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/anie.200461471","article-title":"The composition of Ehrlich's salvarsan: resolution of a century-old debate","volume":"44","author":"Lloyd","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tips.2014.10.007_bib0050","series-title":"Nobel Lecture: Further Progress in Chemotherapy of Bacterial Infections","author":"Domagk","year":"2013"},{"key":"10.1016\/j.tips.2014.10.007_bib0055","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/509S2a","article-title":"Antibiotic resistance: an infectious arms race","volume":"509","author":"Hede","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tips.2014.10.007_bib0060","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1126\/science.1254163","article-title":"Antibiotic effectiveness: balancing conservation against innovation","volume":"345","author":"Laxminarayan","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.tips.2014.10.007_bib0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/431892a","article-title":"Antibiotics: a shot in the arm","volume":"431","author":"Leeb","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tips.2014.10.007_bib0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/431899a","article-title":"Antibiotics at the crossroads","volume":"431","author":"Nathan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tips.2014.10.007_bib0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrd4262","article-title":"An audience with John Reed","volume":"13","author":"Reed","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.007_bib0080","series-title":"The Drugs Don\u2019t Work: A Global Threat","author":"Davies","year":"2013"},{"key":"10.1016\/j.tips.2014.10.007_bib0085","series-title":"Nobel Lectures, Physiology or Medicine 1942\u20131962","first-page":"83","article-title":"Nobel Lecture: Penicillin","author":"Fleming","year":"1945"},{"key":"10.1016\/j.tips.2014.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1303359","article-title":"Transferable vancomycin resistance in a community-associated MRSA lineage","volume":"370","author":"Rossi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2014.10.007_bib0095","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2014.10.007_bib0100","first-page":"CD006201","article-title":"Chemotherapy for second-stage human African trypanosomiasis","volume":"6","author":"Lutje","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2014.10.007_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2202","article-title":"Multi-targeting by monotherapeutic antibacterials","volume":"6","author":"Silver","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.007_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.12006","article-title":"Viable screening targets related to the bacterial cell wall","volume":"1277","author":"Silver","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2014.10.007_bib0115","series-title":"Guidance for Industry \u2013 Codevelopment of Two or More New Investigational Drugs for Use in Combination","author":"Food","year":"2013"},{"key":"10.1016\/j.tips.2014.10.007_bib0120","series-title":"Designing Multi-Target Drugs","author":"Morphy","year":"2012"},{"key":"10.1016\/j.tips.2014.10.007_bib0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Medina-Franco","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tips.2014.10.007_bib0130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/C4MD00069B","article-title":"Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases","volume":"5","author":"Prati","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.tips.2014.10.007_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/17460441.2013.743991","article-title":"Multitarget ligands in antibacterial research: progress and opportunities","volume":"8","author":"East","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.007_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tips.2014.10.007_bib0145","series-title":"Antimicrobials: New and Old molecules in the Fight Against Multi-Resistant Bacteria","first-page":"307","article-title":"Bacterial topoisomerase inhibitors: quinolones and beyond","author":"Pucci","year":"2014"},{"key":"10.1016\/j.tips.2014.10.007_bib0150","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/jm049383s","article-title":"Additivity of molecular fields: CoMFA study on dual activators of PPAR alpha and PPAR gamma","volume":"48","author":"Khanna","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.1219899110","article-title":"Antibacterial drug leads targeting isoprenoid biosynthesis","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2014.10.007_bib0160","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1021\/jm500131s","article-title":"Multitarget drug discovery for tuberculosis and other infectious diseases","volume":"57","author":"Li","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0165","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s11745-008-3261-7","article-title":"From molecular fossils of bacterial hopanoids to the formation of isoprene units: discovery and elucidation of the methylerythritol phosphate pathway","volume":"43","author":"Rohmer","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/j.tips.2014.10.007_bib0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1021\/ml300038t","article-title":"HIV-1 integrase inhibitor-inspired antibacterials targeting isoprenoid biosynthesis","volume":"3","author":"Zhang","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tips.2014.10.007_bib0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.007_bib0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/cbdd.12121","article-title":"Farnesyl diphosphate synthase inhibitors from in silico screening","volume":"81","author":"Lindert","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tips.2014.10.007_bib0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1747-0285.2011.01101.x","article-title":"Applying molecular dynamics simulations to identify rarely sampled ligand-bound conformational states of undecaprenyl pyrophosphate synthase, an antibacterial target","volume":"77","author":"Sinko","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tips.2014.10.007_bib0190","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1073\/pnas.0702254104","article-title":"Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases","volume":"104","author":"Guo","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2014.10.007_bib0195","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/ar100026v","article-title":"Targeting isoprenoid biosynthesis for drug discovery: bench to bedside","volume":"43","author":"Oldfield","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.tips.2014.10.007_bib0200","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0205","doi-asserted-by":"crossref","first-page":"33609","DOI":"10.1074\/jbc.274.47.33609","article-title":"Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs","volume":"274","author":"Urbina","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/bj3160057","article-title":"Pyrophosphate-dependent phosphofructokinase of Entamoeba histolytica: molecular cloning, recombinant expression and inhibition by pyrophosphate analogues","volume":"316","author":"Bruchhaus","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2014.10.007_bib0215","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1006\/bbrc.1999.1404","article-title":"Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis","volume":"263","author":"Martin","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2014.10.007_bib0220","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/ja808285e","article-title":"Lipophilic bisphosphonates as dual farnesyl\/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation","volume":"131","author":"Zhang","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2014.10.007_bib0225","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1073\/pnas.1118215109","article-title":"Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity","volume":"109","author":"No","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2014.10.007_bib0230","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/anie.200905933","article-title":"Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators","volume":"49","author":"Zhang","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tips.2014.10.007_bib0235","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI200113584","article-title":"Antibacterial effect of human V\u03b32V\u03b42 T cells in vivo","volume":"108","author":"Wang","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2014.10.007_bib0240","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd1167","article-title":"Doing the two step","volume":"2","author":"Ellis","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2014.10.007_bib0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.300.1.195","article-title":"Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone","volume":"300","author":"Courchesne","year":"2002","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tips.2014.10.007_bib0250","doi-asserted-by":"crossref","first-page":"28831","DOI":"10.1074\/jbc.M303300200","article-title":"Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis","volume":"278","author":"Gupta","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0255","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm050691f","article-title":"Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole","volume":"49","author":"Benaim","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0260","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrcardio.2012.108","article-title":"The emerging role of amiodarone and dronedarone in Chagas disease","volume":"9","author":"Benaim","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.tips.2014.10.007_bib0265","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/TCRM.S2801","article-title":"Concurrent Chagas\u2019 disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug","volume":"4","author":"Paniz-Mondolfi","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.tips.2014.10.007_bib0270","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000219436","article-title":"Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas\u2019 disease","volume":"55","author":"Paniz-Mondolfi","year":"2009","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tips.2014.10.007_bib0275","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dki319","article-title":"Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines","volume":"56","author":"Protopopova","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tips.2014.10.007_bib0280","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.05708-11","article-title":"SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis","volume":"56","author":"Tahlan","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2014.10.007_bib0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tips.2014.10.007_bib0290","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1371\/journal.pntd.0001216","article-title":"Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with ambisome","volume":"5","author":"Cencig","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tips.2014.10.007_bib0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/129.1.53","article-title":"Resistance to polyene antibiotics and correlated sterol changes in 2 isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria","volume":"129","author":"Woods","year":"1974","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2014.10.007_bib0300","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrmicro1839","article-title":"Membrane lipid homeostasis in bacteria","volume":"6","author":"Zhang","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tips.2014.10.007_bib0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tips.2014.10.007_bib0310","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/0006-291X(86)90452-3","article-title":"Mycobacteria possess a surprisingly small number of ribosomal-RNA genes in relation to the size of their genome","volume":"136","author":"Bercovier","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2014.10.007_bib0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"Munday","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tips.2014.10.007_bib0320","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1021\/bi00146a011","article-title":"Crystal structure of a pentamidine-oligonucleotide complex: Implications for DNA-binding properties","volume":"31","author":"Edwards","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2014.10.007_bib0325","series-title":"Proceedings of the Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"The mechanism of antibacterial action of novel bis-indole antibiotics","author":"Opperman","year":"2010"},{"key":"10.1016\/j.tips.2014.10.007_bib0330","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/abbi.1996.0041","article-title":"Pentamidine is an uncoupler of oxidative phosphorylation in rat liver mitochondria","volume":"326","author":"Moreno","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tips.2014.10.007_bib0335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1568026613666131113154753","article-title":"Progress in the discovery of treatments for C. difficile infection: a clinical and medicinal chemistry review","volume":"14","author":"Tsutsumi","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0340","unstructured":"Ravic, M. et al. (2012) Disposition of MGB-BP-3, a new class of antibacterial agent, after oral administration in a hamster model of severe Clostridium difficile associated diarrhoea (CDAD). In 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tips.2014.10.007_bib0345","series-title":"Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary","author":"Institute of Medicine (US) Forum on Microbial Threats","year":"2010"},{"key":"10.1016\/j.tips.2014.10.007_bib0350","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs?","volume":"12","author":"Allen","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tips.2014.10.007_bib0355","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1084\/jem.20050846","article-title":"Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity","volume":"202","author":"Liu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2014.10.007_bib0360","first-page":"450","article-title":"Pigments of pathogens might provide golden antimicrobial opportunities","volume":"71","author":"Potera","year":"2005","journal-title":"ASM News"},{"key":"10.1016\/j.tips.2014.10.007_bib0365","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.1153018","article-title":"A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence","volume":"319","author":"Liu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tips.2014.10.007_bib0370","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/jm950735s","article-title":"Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the \u03b1-phosphonosulfonic acid moiety","volume":"39","author":"Dickson","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2014.10.007_bib0375","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1073\/pnas.1315883111","article-title":"Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c","volume":"111","author":"Layre","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2014.10.007_bib0380","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1021\/ja413127v","article-title":"Structure and inhibition of tuberculosinol synthase and decaprenyl diphosphate synthase from Mycobacterium tuberculosis","volume":"136","author":"Chan","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2014.10.007_bib0385","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.chom.2010.10.005","article-title":"Statins enhance formation of phagocyte extracellular traps","volume":"8","author":"Chow","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tips.2014.10.007_bib0390","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/cmdc.201100589","article-title":"Dual dehydrosqualene\/squalene synthase inhibitors: leads for innate immune system-based therapeutics","volume":"7","author":"Lin","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tips.2014.10.007_bib0395","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/anie.201306712","article-title":"Bioorganometallic chemistry with IspG and IspH: Structure, function, and inhibition of the [Fe4S4] proteins involved in isoprenoid biosynthesis","volume":"53","author":"Wang","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.tips.2014.10.007_bib0400","doi-asserted-by":"crossref","first-page":"e1003501","DOI":"10.1371\/journal.ppat.1003501","article-title":"Phosphoantigen\/IL2 expansion and differentiation of V\u03b32V\u03b42 T cells increase resistance to tuberculosis in nonhuman primates","volume":"9","author":"Chen","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tips.2014.10.007_bib0405","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4049\/jimmunol.1302746","article-title":"Metabolic engineering of Salmonella vaccine bacteria to boost human V\u03b32V\u03b42 T cell immunity","volume":"193","author":"Workalemahu","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2014.10.007_bib0410","series-title":"The Importance of Being Earnest: A Trivial Comedy for Serious People","author":"Wilde","year":"1899"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614714001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614714001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T09:49:37Z","timestamp":1584006577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614714001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0165614714001722"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2014.10.007","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance-resistant antibiotics","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}